Chris Spencer Director / Addiction Specialist
4th March, 2026
Review by: Chris Spencer, Addiction Specialist

Benzodiazepines After Conflict: Relief vs Dependence Risk

- Mental Health and Addiction Treatment Centre

Middle East Conflict and the Quiet Surge in Tranquillisers: When Short-Term Relief Risks Long-Term Dependence

When a society is hit by mass trauma, war, attacks, displacement, and ongoing uncertainty, anxiety rarely stays contained inside the individual.

It becomes widespread. Sleep breaks down. Concentration drops. Parents become hypervigilant. The nervous system stays switched on.

In that climate, many people do what any rational person would do: they seek relief.

Often that means going to a doctor for medication that works quickly for acute anxiety and insomnia, so called “tranquillisers,” most commonly benzodiazepines (and related sedatives).

Used carefully, these medicines can help. Used without a plan, they can become an unintended entry point into tolerance, dependence, and difficult withdrawal, especially when fear persists long after the initial shock.
 Middle East Conflict and the Quiet Surge in Tranquillisers: When Short-Term Relief Risks Long-Term Dependence

What the evidence shows: prescribing can rise sharply after mass trauma

Population level research shows prescribing patterns can change dramatically after major traumatic events. Studies have found that after mass trauma:
Total benzodiazepine prescriptions can rise by over 200% in the first week
Remain around 50% higher over the following month
While first-time prescriptions can increase even more sharply, sometimes ten-fold in the acute phase.
These figures won’t replicate identically in every conflict or country. Prescribing changes depend on healthcare access, public messaging, culture, and how long the stressor continues.

But the clinical signal matters: in the weeks following mass trauma, both ongoing prescribing and first-time exposure can rise quickly.

Why people seek fast relief during conflict

Conflict related stress tends to produce a predictable cluster: insomnia (including early waking), panic symptoms (tight chest, shaking, breathlessness), intrusive thoughts and images, hypervigilance and startle response, and the emotional swing between irritability, grief, and numbness.

Patients often put it plainly: “I can’t switch my mind off.” In that moment, a medicine that rapidly calms the nervous system can feel like a lifeline.

Benzodiazepines: where they help and where they harm

Where they can help

Benzodiazepines can have a place in short term, acute distress, particularly when symptoms are severe enough to impair functioning and immediate stabilisation is needed. In the best-case scenario, they act as a temporary bridge while the person regains sleep, reduces physiological arousal, and builds non-medication supports.

The core risk: tolerance, rebound, dependence

The risk isn’t only “misuse.” It’s neuroadaptation. With repeated use, the brain adjusts. Two patterns follow: tolerance (the same dose becomes less effective) and rebound symptoms (reducing or stopping can trigger worse anxiety and insomnia, making it feel as if the medication is now “required”). This is how short term prescribing can drift into long term use, especially when follow-up is disrupted and fear remains chronic.

First time prescriptions matter: the “entry point” problem

First exposure can shape a powerful coping belief:
“This is the only thing that works.”
“If I don’t have it, I can’t cope.”
“I’ll deal with the bigger issues later.”
That’s not weakness; it’s conditioned relief. But it can make stopping much harder later, particularly in prolonged conflict settings.

A brief vignette clinicians will recognise

I’ve worked with people who began a sedative exactly as prescribed for sleep during a period of heightened threat. Weeks later they tried to stop, only to find their sleep and anxiety rebounded intensely. They concluded, “I must still need it.” What they were experiencing was often rebound and dependence physiology, not a failure of will.

Benzodiazepine rebound and withdrawal: what patients often report

When reliance has built up, patients commonly describe a specific pattern: sleep fragments, the mind feels “wired,” and daytime anxiety spikes, sometimes with tremor, restlessness, irritability, and internal agitation. Many interpret this as their original anxiety “coming back,” when it may be rebound or withdrawal physiology. Naming that early can prevent escalation and reduce repeat prescribing.

A clinician’s observation from the region

From my experience working clinically in the Middle East, multidisciplinary teams often discussed broad patterns of substance use under stress. Prescription sedatives and “calming tablets” were frequently near the top, sometimes medically initiated for legitimate symptoms, and sometimes followed by informal sharing once their short-term effect became widely known.

This isn’t a moral judgement. It’s a public health reality: when fear becomes normal, sedation becomes tempting, and dependence can grow quietly.
Benzodiazepines After Conflict: Relief vs Dependence Risk

Safer prescribing during prolonged stress

In conflict affected environments, prescribers face short appointments, overloaded services, and distressed patients. The answer isn’t “never prescribe.” The answer is prescribe with an exit strategy.

Be explicit about time-limited use

State the intention clearly: short term use, lowest effective dose, and a review date.

Keep quantities small and reviews frequent

Smaller quantities reduce silent repeats and create natural follow up points: what symptom is it targeting (panic, sleep, or both), is it improving, and is the medication still necessary?

Explain the risk without frightening the patient

A practical script:
“This can help short-term, but daily use can create dependence.”
“We’ll review soon and build other supports in parallel.”
If use continues, taper, don’t stop abruptly

A crucial safety point: people should not stop benzodiazepines abruptly. If use has continued beyond a short period, discontinuation should be planned and supervised by the prescriber, using a structured taper when appropriate.

What patients can do: relief plus resilience

If you’re considering (or already using) tranquilliser-type medication for anxiety or sleep, these steps reduce risk.

Ask three simple questions
1. What is the goal, sleep, panic, or both?
2. When is the review date?
3. What is the plan to come off safely if I’m still taking it in a few weeks?
Build non medication supports immediately

Medication may reduce intensity; coping skills reduce long-term reliance. Protective supports include sleep stabilisation (consistent wake time and reducing late-night news), grounding/breathing skills, gentle exercise and daylight exposure, trauma-informed counselling where available, limiting “doom-scrolling” with planned news windows, and community connection with daily structure.

These aren’t “soft options.” They are the foundations that restore self-regulation.

URGENT ANXIETY CARE WITHOUT DEPENDENCE

Choose the Right Rehab Treatment Centre in the UK, Ireland & Spain

Clinician FAQ: benzodiazepines, conflict-related anxiety, and dependence risk

Should benzodiazepines be avoided entirely after trauma?

Not necessarily. They can be appropriate for short-term stabilisation in acute distress. The key is time-limited prescribing, clear review, and parallel non-medication support, so a short-term bridge doesn’t become long-term dependence.

What are early warning signs that use is drifting into dependence?

Common indicators include escalating dose, taking “just in case,” anxiety about running out, difficulty sleeping without it, and rebound anxiety/insomnia between doses. Family members may notice emotional flattening, reduced motivation, or increasing avoidance.

What should I tell patients who say, “I’m not abusing it, I’m taking it as prescribed”?

Validate the intent, then educate gently: dependence can occur with regular use even when taken exactly as directed. Emphasise safe, planned use with a review date and an exit strategy.

What’s the safest approach if the patient has been taking them longer than intended?

Avoid abrupt cessation. Review dose, duration, co-prescribed substances, and comorbidities, then agree a gradual taper plan tailored to the patient’s stability and risk profile. Where indicated, coordinate with specialist support.

What reduces repeat prescribing pressure in a busy primary care setting?

Small quantities, a scheduled review date, simple patient education (tolerance/rebound), and a parallel plan for sleep and anxiety support. Even brief behavioural guidance plus signposting reduces reliance on medication alone.

The core message: treat anxiety urgently, without creating the next crisis

Conflict causes real psychological injury. People deserve compassionate care and effective symptom relief. But if we respond to mass trauma with widespread long-term sedative prescribing without clear review and exit plans, we risk a second wave of harm, dependence, withdrawal, and functional decline, months after the headlines move on.

A balanced approach is possible: use medication selectively, keep it time limited, review it actively, and pair it with supports that restore coping capacity.

Next step: if you’re worried about dependence

If you (or a family member) have started benzodiazepines for anxiety or sleep and feel concerned about increasing dose, reliance, or difficulty stopping, get support early. A calm review, symptoms, dose, duration, and a realistic taper plan when needed, can prevent a temporary measure from becoming a long term problem.

At Phoenix Programmes, we help clients and families navigate anxiety, medication reliance, and addiction risk with discreet, medically informed support, especially where stress and trauma are part of the picture.
If you think that you or someone you love might have a problem with drug or alcohol addiction, compulsive behaviour or emotional disorders, reach out and speak to our specialist addiction rehab treatment team on our confidential helpline +34 691 881 422. Immediate admission available.

Working Hours

Address

Follow Us

Individual Treatment in Spain

Individual Treatment in Spain

Treatment at Your Residence

Exclusive Individual Treatment Programme at Your Residence